Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
XHAM:MUV2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
XHAM:MUV2
|
DE |
|
H
|
Heidelberg Pharma AG
XHAM:HPHA
|
DE |
|
V
|
Vulcan Materials Co
DUS:VMC
|
US |
|
Capricor Therapeutics Inc
F:4LN2
|
US |
|
S
|
Standard Chartered PLC
SWB:STD
|
UK |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
XMUN:MOH
|
FR |
|
Norcros PLC
F:3N1N
|
UK |
|
I
|
Ingredion Inc
XBER:CNP
|
US |
|
D
|
Dell Technologies Inc
F:12DA
|
US |
|
G
|
Goldman Sachs Group Inc
XHAM:GOS
|
US |
Wall St Price Targets
MUV2 Price Targets Summary
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
According to Wall Street analysts, the average 1-year price target for MUV2 is 607.29 EUR with a low forecast of 508.88 EUR and a high forecast of 703.61 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MUV2's stock price target?
Price Target
607.29
EUR
According to Wall Street analysts, the average 1-year price target for MUV2 is 607.29 EUR with a low forecast of 508.88 EUR and a high forecast of 703.61 EUR.
What is the Revenue forecast for Muenchener Rueckversicherungs Gesellschaft in Muenchen AG?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Muenchener Rueckversicherungs Gesellschaft in Muenchen AG?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 8 years is 4%.
